REZDIFFRA Film-coated tablet Ref.[116002] Active ingredients: Resmetirom

Source: European Medicines Agency (EU)  Revision Year: 2025  Publisher: Madrigal Pharmaceuticals EU Limited, 1 Castlewood Avenue, Dublin, D06 H685, Ireland

Product name and form

Rezdiffra 60 mg film-coated tablets.

Rezdiffra 80 mg film-coated tablets.

Rezdiffra 100 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet.

Rezdiffra 60 mg film-coated tablets: White, oval film-coated tablets with "P60" debossed on one side and plain on the other side. Approximate tablet dimensions 6.4 mm x 12.2 mm.

Rezdiffra 80 mg film-coated tablets: Yellow, oval film-coated tablets with "P80" debossed on one side and plain on the other side. Approximate tablet dimensions 7.1 mm x 13.5 mm.

Rezdiffra 100 mg film-coated tablets: Beige to pinkish, oval film-coated tablets with "P100" debossed on one side and plain on the other side. Approximate tablet dimensions 7.6 mm x 14.6 mm.

Qualitative and quantitative composition

Rezdiffra 60 mg film-coated tablets: Each film-coated tablet contains 60 mg of resmetirom.

Rezdiffra 80 mg film-coated tablets: Each film-coated tablet contains 80 mg of resmetirom.

Rezdiffra 100 mg film-coated tablets: Each film-coated tablet contains 100 mg of resmetirom.

For the full list of excipients, see section 6.1.

Active Ingredient

Resmetirom is a liver-directed partial agonist for the thyroid hormone receptor beta (THR-β). Stimulation of THR-β in the liver improves mitochondrial function and lipid metabolism, and increases fatty acid β-oxidation, thereby reducing lipotoxic liver fat, inflammation and liver fibrosis. Resmetirom's liver directed THR-β agonism is particularly relevant in the treatment of MASH and leads to minimal off-target activity on THR-α in tissues such as heart and bone.

List of Excipients

Tablet core:

Microcrystalline cellulose
Mannitol
Croscarmellose sodium
Colloidal anhydrous silica
Magnesium stearate

Tablet coating:

Rezdiffra 60 mg film-coated tablets

Poly(vinyl alcohol)
Titanium dioxide (E171)
Macrogol
Talc

Rezdiffra 80 mg film-coated tablets

Poly(vinyl alcohol)
Titanium dioxide (E171)
Macrogol
Talc
Yellow iron oxide (E172)

Rezdiffra 100 mg film-coated tablets

Poly(vinyl alcohol)
Titanium dioxide (E171)
Macrogol
Talc
Yellow iron oxide (E172)
Red iron oxide (E172)

Pack sizes and marketing

Rezdiffra film-coated tablets are supplied in PVC/PCTFE blisters with aluminium foil lidding.

Pack size of 28 film-coated tablets.

Marketing authorization holder

Madrigal Pharmaceuticals EU Limited, 1 Castlewood Avenue, Dublin, D06 H685, Ireland

Marketing authorization dates and numbers

EU/1/25/1962/001
EU/1/25/1962/002
EU/1/25/1962/003

Drugs

Drug Countries
REZDIFFRA Austria, Estonia, France, Italy, Lithuania, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.